AC
AI Cancer Cure
Evidence Atlas, updating nightly
Trials
Research
Support
Alternatives
Cancers
Biomarkers
Updates
Roadmap
Explore
← Back to trials
Trial not found
Could not find
NCT06456138
in the database yet.
Trametinib Plus Anlotinib Combined With Tislelizumab in KRAS-mutant NSCLC | AI Cancer Cure